News
Enabling long term investment in innovative companies
Nuclear Liabilities Fund invests £250m alongside British Patient Capital to enable long term investment in innovative companies across the UK.

Nuclear Liabilities Fund invests £250m alongside British Patient Capital to enable long term investment in innovative companies across the UK.